-
1
-
-
0030917202
-
ONYX-015, an E1b gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents
-
DOI 10.1038/nm0697-639
-
Heise C, Sampson-Johannes A, Williams A, McCormick F, Von Hoff DD and Kirn DH: ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat Med 3: 639-645, 1997. (Pubitemid 27264973)
-
(1997)
Nature Medicine
, vol.3
, Issue.6
, pp. 639-645
-
-
Heise, C.1
Sampson-Johannes, A.2
Williams, A.3
McCormick, F.4
Von Hoff, D.D.5
Kirn, D.H.6
-
2
-
-
0033782862
-
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
-
Heise C, Hermiston T, Johnson L, et al.: An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy. Nat Med 6: 1134-1139, 2000.
-
(2000)
Nat Med
, vol.6
, pp. 1134-1139
-
-
Heise, C.1
Hermiston, T.2
Johnson, L.3
-
3
-
-
0034610723
-
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
-
Fueyo J, Gomez-Manzano C, Alemany R, et al.: A mutant oncolytic adenovirus targeting the Rb pathway produces antiglioma effect in vivo. Oncogene 19: 2-12, 2000. (Pubitemid 30066345)
-
(2000)
Oncogene
, vol.19
, Issue.1
, pp. 2-12
-
-
Fueyo, J.1
Gomez-Manzano, C.2
Alemany, R.3
Lee, P.S.Y.4
McDonnell, T.J.5
Mitlianga, P.6
Shi, Y.-X.7
Levin, V.A.8
Yung, W.K.A.9
Kyritsis, A.P.10
-
4
-
-
0042674013
-
Telomerase-dependent oncolytic adenovirus for cancer treatment
-
DOI 10.1038/sj.gt.3301987
-
Huang TG, Savontaus MJ, Shinozaki K, Sauter BV and Woo SL: Telomerase-dependent oncolytic adenovirus for cancer treatment. Gene Ther 10: 1241-1247, 2003. (Pubitemid 36934726)
-
(2003)
Gene Therapy
, vol.10
, Issue.15
, pp. 1241-1247
-
-
Huang, T.-G.1
Savontaus, M.J.2
Shinozaki, K.3
Sauter, B.V.4
Woo, S.L.C.5
-
5
-
-
76349110981
-
Current issues and future directions of oncolytic adenoviruses
-
Yamamoto M and Curiel DT: Current issues and future directions of oncolytic adenoviruses. Mol Ther 18: 243-250, 2010.
-
(2010)
Mol Ther
, vol.18
, pp. 243-250
-
-
Yamamoto, M.1
Curiel, D.T.2
-
6
-
-
0035138484
-
Differential effects of adenovirus-p16 on bladder cancer cell lines can be overcome by the addition of butyrate
-
Lee CT, Seol JY, Park KH, et al.: Differential effects of adenovirus-p16 on bladder cancer cell lines can be overcome by the addition of butyrate. Clin Cancer Res 7: 210-214, 2001.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 210-214
-
-
Lee, C.T.1
Seol, J.Y.2
Park, K.H.3
-
7
-
-
14544280192
-
Valproic acid enhances gene expression from viral gene transfer vectors
-
DOI 10.1016/j.jviromet.2004.11.023
-
Fan S, Maguire CA, Ramirez SH, et al.: Valproic acid enhances gene expression from viral gene transfer vectors. J Virol Methods 125: 23-33, 2005. (Pubitemid 40298810)
-
(2005)
Journal of Virological Methods
, vol.125
, Issue.1
, pp. 23-33
-
-
Fan, S.1
Maguire, C.A.2
Ramirez, S.H.3
Bradel-Tretheway, B.4
Sapinoro, R.5
Sui, Z.6
Chakraborty-Sett, S.7
Dewhurst, S.8
-
8
-
-
0242610345
-
The Histone Deacetylase Inhibitor FK228 Preferentially Enhances Adenovirus Transgene Expression in Malignant Cells
-
Goldsmith ME, Kitazono M, Fok P, Aikou T, Bates S and Fojo T: The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells. Clin Cancer Res 9: 5394-5401, 2003. (Pubitemid 37413595)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.14
, pp. 5394-5401
-
-
Goldsmith, M.E.1
Kitazono, M.2
Fok, P.3
Aikou, T.4
Bates, S.5
Fojo, T.6
-
9
-
-
0035418558
-
Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228
-
Kitazono M, Goldsmith ME, Aikou T, Bates S and Fojo T: Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228. Cancer Res 61: 6328-6330, 2001. (Pubitemid 32783231)
-
(2001)
Cancer Research
, vol.61
, Issue.17
, pp. 6328-6330
-
-
Kitazono, M.1
Goldsmith, M.E.2
Aikou, T.3
Bates, S.4
Fojo, T.5
-
10
-
-
33847302895
-
Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity
-
VanOosten RL, Earel JK Jr, and Griffith TS: Histone deacetylase inhibitors enhance Ad5-TRAIL killing of TRAIL-resistant prostate tumor cells through increased caspase-2 activity. Apoptosis 12: 561-571, 2007.
-
(2007)
Apoptosis
, vol.12
, pp. 561-571
-
-
VanOosten, R.L.1
Earel Jr., J.K.2
Griffith, T.S.3
-
11
-
-
0030984807
-
Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase
-
DOI 10.1006/viro.1997.8538
-
Dion LD, Goldsmith KT, Tang DC, Engler JA, Yoshida M and Garver RI Jr: Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase. Virology 231: 201-209, 1997. (Pubitemid 27244186)
-
(1997)
Virology
, vol.231
, Issue.2
, pp. 201-209
-
-
Dion, L.D.1
Goldsmith, K.T.2
Tang, D.-C.3
Engler, J.A.4
Yoshida, M.5
Garver Jr., R.I.6
-
12
-
-
79959380355
-
Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells
-
Kim DR, Park MY, Lee CS, et al.: Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells. Cancer Gene Ther 18: 467-477, 2011.
-
(2011)
Cancer Gene Ther
, vol.18
, pp. 467-477
-
-
Kim, D.R.1
Park, M.Y.2
Lee, C.S.3
-
13
-
-
77953544825
-
Oncolytic viruses and histone deacetylase inhibitors - A multi-pronged strategy to target tumor cells
-
Nguyen TL, Wilson MG and Hiscott J: Oncolytic viruses and histone deacetylase inhibitors - a multi-pronged strategy to target tumor cells. Cytokine Growth Factor Rev 21: 153-159, 2010.
-
(2010)
Cytokine Growth Factor Rev
, vol.21
, pp. 153-159
-
-
Nguyen, T.L.1
Wilson, M.G.2
Hiscott, J.3
-
14
-
-
33751248498
-
Valproic Acid, a Histone Deacetylase Inhibitor, Is an Antagonist for Oncolytic Adenoviral Gene Therapy
-
DOI 10.1016/j.ymthe.2006.07.009, PII S1525001606014869
-
Hoti N, Chowdhury W, Hsieh JT, Sachs MD, Lupold SE and Rodriguez R: Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy. Mol Ther 14: 768-778, 2006. (Pubitemid 44780612)
-
(2006)
Molecular Therapy
, vol.14
, Issue.6
, pp. 768-778
-
-
Hoti, N.1
Chowdhury, W.2
Hsieh, J.-T.3
Sachs, M.D.4
Lupold, S.E.5
Rodriguez, R.6
-
15
-
-
70350118707
-
RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses
-
Shiina M, Lacher MD, Christian C and Korn WM: RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses. Cancer Gene Ther 16: 810-819, 2009.
-
(2009)
Cancer Gene Ther
, vol.16
, pp. 810-819
-
-
Shiina, M.1
Lacher, M.D.2
Christian, C.3
Korn, W.M.4
-
16
-
-
77954816343
-
Armoring CRAds with p21/Waf-1 shRNAs: The next generation of oncolytic adenoviruses
-
Hoti N, Chowdhury WH, Mustafa S, et al.: Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses. Cancer Gene Ther 17: 585-597, 2010.
-
(2010)
Cancer Gene Ther
, vol.17
, pp. 585-597
-
-
Hoti, N.1
Chowdhury, W.H.2
Mustafa, S.3
-
17
-
-
29144485434
-
Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells
-
DOI 10.1016/j.yexcr.2005.10.026, PII S0014482705004829
-
Watanabe T, Hioki M, Fujiwara T, et al.: Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. Exp Cell Res 312: 256-265, 2006. (Pubitemid 41814835)
-
(2006)
Experimental Cell Research
, vol.312
, Issue.3
, pp. 256-265
-
-
Watanabe, T.1
Hioki, M.2
Fujiwara, T.3
Nishizaki, M.4
Kagawa, S.5
Taki, M.6
Kishimoto, H.7
Endo, Y.8
Urata, Y.9
Tanaka, N.10
Fujiwara, T.11
-
18
-
-
30744452281
-
Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: Histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520
-
DOI 10.1089/hum.2006.17.55
-
Bieler A, Mantwill K, Dravits T, et al.: Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520. Hum Gene Ther 17: 55-70, 2006. (Pubitemid 43100515)
-
(2006)
Human Gene Therapy
, vol.17
, Issue.1
, pp. 55-70
-
-
Bieler, A.1
Mantwill, K.2
Dravits, T.3
Bernshausen, A.4
Glockzin, G.5
Kohler-Vargas, N.6
Lage, H.7
Gansbacher, B.8
Holm, P.S.9
-
19
-
-
54449089024
-
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
-
Nguyen TL, Abdelbary H, Arguello M, et al.: Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis. Proc Natl Acad Sci USA 105: 14981-14986, 2008.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 14981-14986
-
-
Nguyen, T.L.1
Abdelbary, H.2
Arguello, M.3
-
20
-
-
77954882437
-
P21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker
-
Flak MB, Connell CM, Chelala C, et al.: p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker. Mol Cancer 9: 175, 2010.
-
(2010)
Mol Cancer
, vol.9
, pp. 175
-
-
Flak, M.B.1
Connell, C.M.2
Chelala, C.3
-
21
-
-
32944465688
-
Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: Class differences and the potential influence of p53
-
DOI 10.1158/1078-0432.CCR-05-1230
-
Kim IA, Shin JH, Kim IH, et al.: Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53. Clin Cancer Res 12: 940-949, 2006. (Pubitemid 43259877)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.3 I
, pp. 940-949
-
-
Kim, I.A.1
Shin, J.H.2
Kim, I.H.3
Kim, J.H.4
Kim, J.S.5
Wu, H.G.6
Chie, E.K.7
Ha, S.W.8
Park II, C.9
Kao, G.D.10
-
22
-
-
77955519631
-
Oncolytic-adenovirus-expressed RNA interference for cancer therapy
-
Pei DS, Di JH, Chen FF and Zheng JN: Oncolytic-adenovirus-expressed RNA interference for cancer therapy. Expert Opin Biol Ther 10: 1331-1341, 2010.
-
(2010)
Expert Opin Biol Ther
, vol.10
, pp. 1331-1341
-
-
Pei, D.S.1
Di, J.H.2
Chen, F.F.3
Zheng, J.N.4
-
23
-
-
34250696097
-
Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignancies
-
DOI 10.1158/1078-0432.CCR-07-0162
-
Ramalingam SS, Parise RA, Ramanathan RK, et al.: Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignancies. Clin Cancer Res 13: 3605-3610, 2007. (Pubitemid 46955122)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.12
, pp. 3605-3610
-
-
Ramalingam, S.S.1
Parise, R.A.2
Ramananthan, R.K.3
Lagattuta, T.F.4
Musguire, L.A.5
Stoller, R.G.6
Potter, D.M.7
Argiris, A.E.8
Zwiebel, J.A.9
Egorin, M.J.10
Belani, C.P.11
|